[April Shanghai CMTF] Gathering 300 Overseas Institutions & Domestic Leaders!

Exhibition Basic Information

  • Exhibition Name:

    Zhenghe · CMTF 26th Shanghai International Medical Tourism Exhibition

    16th Cell Biology Industry, Cell Therapy and Regenerative Medicine Conference

    9th International Functional Medicine and Longevity Technology Innovation Conference


  • Dates: April 23 – 25, 2026

    • Thursday, April 23: 08:30 – 17:00

    • Friday, April 24: 08:30 – 17:00

    • Saturday, April 25: 08:30 – 15:00 (Entry stops at 15:00)


  • Location: Shanghai Exhibition Center (No. 1000 Middle Yan'an Road, Jing'an District, Shanghai)

  • Annual Schedule: April (Shanghai) | July (Shenzhen) | November (Beijing) | March (Chengdu)

  • Organizer Contact: +86-13570219945 (Phone & WeChat & Whatsapp)

Exhibition Core Value

Global demographic changes and upgrading health needs are driving the medical industry's transformation from traditional disease treatment to full-life-cycle health management. Continuous breakthroughs in frontier fields—such as assisted reproduction, cancer treatment, cell therapy, regenerative medicine, and functional medicine—are reshaping global medical service models, technology pathways, and the industrial landscape.

The Zhenghe · International Medical Tourism Exhibition serves as a premier display platform for frontier medical technologies, a hub for the deep integration of cross-border healthcare with functional medicine/cell biology, and a weather vane for global industry trends and resource linking.

I. Exhibition Core Positioning

Target Audiences:

  • Medical & Health Practitioners: For technology upgrades, knowledge renewal, global medical resource docking, and grasping industry trends.

  • Channels / Agents / Investors: For direct access to global hospitals, understanding innovative therapies, discovering blockbuster products, and seizing industrial layout opportunities.

  • People with Health Needs: Subverting traditional health cognition with one-stop access to global medical and health solutions.

Covered Fields:

  • Assisted reproduction, precision physical examinations, cancer diagnosis & treatment, critical care.

  • Cell therapy, stem cells & regenerative medicine, medical aesthetics, anti-aging.

  • Chronic disease management, fecal microbiota transplantation (FMT), gut microecology reconstruction.

  • Longevity technologies (NAD+, NMN, etc.), hyperbaric oxygen chambers, and health equipment.

II. Exhibition Highlights

  • 300+ International Hospitals & Enterprises: Gathering core players across international medical, functional medicine, and cell biology industries. Presenting full-chain solutions from "treatment" to "prevention" and from "life extension" to "age reversal."

  • 4 Major Forum Areas | 200+ Professional Lectures: Covering all-dimensional topics including technology, clinical practice, policy, market trends, and cooperation.

  • 25,000+ Professional Visitors & High-Net-Worth Individuals: Building a highly efficient platform for resource docking and partnership.

III. Full Scope of Exhibition

  1. Medical Tourism: Global high-quality medical resources covering assisted reproduction, precision physical exams, cancer, critical care, cell therapy, stem cell regeneration, medical aesthetics and anti-aging, imported drugs, and health & wellness tourism.

  2. Functional Medicine & Longevity Tech: Chronic disease management, delayed food allergy testing, flora transplantation, gut microecology, NAD+/NMN/ergothioneine, methylation, hyperbaric oxygen chambers, and hormone management.

  3. Cell Biology Industry: Cell therapy, stem cells, exosomes, drug R&D, cell instruments and consumables, lab equipment, and innovative biotechnology services and applications.

IV. First Batch of Expert Lineup (Partial)

1. The Innovation Wave of Cell Therapy: Tech Breakthroughs & Clinical Translation Forum

  • Zhongyuan Union Cell & Gene Engineering

  • Seiji Ogawa (Dean, Tokyo ART Clinic / Chief Doctor & Professor, Fujita Health University Reproductive Center, Japan): Regenerative Medicine Pioneers the Future of Infertility Treatment—New Measures for Ovarian Function Improvement in Advanced-Age Women & Patients with Ovarian Insufficiency

  • Guo Jun (Founder, Nanjing Poyacell Biotechnology Co., Ltd.): Natural Exosomes—Opening a New Era of Regenerative Medicine

  • SinoCells:

  • Miao Zhenwei (Chairman & CEO, InxMed (Hangzhou) Biopharma): Application of Universal Off-the-Shelf NK Cells in Tumor Clinical Treatment and Prognosis Management

  • Huang Zhe (Executive Dean, Xinrui Health): Stem Cell Technology: The Innovative Path of Knee Osteoarthritis Treatment from "Delay" to "Regeneration"

  • Bai Yongquan (Senior Partner & Dean of Medical Health Industry Law Research Institute, Huashang Law Firm): Opportunities Under the "No. 818" Policy

  • He Xiangfeng (CMO, InxMed): InxMed's Dual-Track Strategy Under the "818/828" New Policies

  • Zhang Rukui (Technical Advisor, Shanghai Lingkang Century Biomedical Technology): Tumor Big Data Center and Trusted Data Space Construction

  • Iwamoto Internal Medicine Clinic:(Topic TBA)

  • Yang Xinzhu (Director of Medical Health Management, Liangkang Medical Laboratory): From "Fuzzy Anti-Aging" to "Precision Intervention": How Functional Medicine Testing Navigates Cell Therapy and Longevity Management

2. Frontier Forum on Regenerative Medicine: iPSC and Exosome-Driven Clinical Translation & Industrial Innovation

  • Ma Fang (R&D Director, Ehang (Suzhou) Biopharma): Multi-Source Innovation and Industrialization Breakthroughs: Exosomes Driving New Transformations in Global Health

  • Wang Zi'ang (O&M Manager, Hangzhou Exosome Biomaterials Tech): Global Clinical Application Progress of Exosomes

  • Chi Xintong (BD Director, Beijing EchoBiotech): Latest Clinical Research Progress on Magical Cell Vesicles

  • Taisei Kageyama (Medical Corporation Yugokai Takanawa Clinic Group): Advanced Regenerative Medical Care Changing the Future

  • Hu Yihan (General Manager, Ciming Boao International Hospital): Stem Cells - From "Sugar Control" to "Reversal": Empowering the Reconstructed Future of Type 2 Diabetes Treatment

  • Chen Gecheng (Scientist, European Wellness Biomedical Group): Neurodegenerative Diseases Including Dementia, Alzheimer's, Parkinson's, and Huntington's Disease

  • Shenzhen Youwendu Bioengineering Co., Ltd.:(Topic TBA)

  • Yang Derong (Academic Director, Beijing Mingrui Tech / Chief Researcher, Medical Regenerative Medicine Research Institute): Breaking Limits: Releasing the Energy of PRP, Exosomes, and Cells

3. Stem Cells from Basic Research to Clinical Application Forum

  • Anhui Shouning Biotechnology:(Topic TBA)

  • Gu Ying (CEO, BGI Cell): Regeneration, Anti-Aging, and Stem Cells: From Research to Application

  • Zhang Aoyu (CEO, Hangzhou New Era Tech): The Necessity of Immune Cell Storage and Channel Investment Policies

  • Wu Dongcheng (Chairman, Qinhuangdao Beidaihe Hamilton Biotech): Human Umbilical Cord Mesenchymal Stem Cells in Treating Metabolic Dysfunction-Associated Steatohepatitis

  • Zhang Ying (Founder & CTO, Help Stem Cell Innovations): Development Progress of iPSC-Derived Cell Drugs

  • Shigeki Sugii (Scientist, Cellastar Stem Cell Center): Cellastar's Characteristic Technological Breakthroughs in Cell Combination Therapy

4. International Medical & Health Forum

  • Shigenori Goto (MD, Chairman of Medical Corporation Koshikai, Seta Clinic Tokyo): Cancer Cell Immunotherapy at Seta Clinic Tokyo—Personalized Therapy and Suppressive T Cell Release

  • Kenichi Higashiyama (President, Japan Juntou Co., Ltd. / Chairman, International Health Science Research Institute): Japan's New Technology for Comprehensive Cancer Treatment Using the Cancer-Immunity Cycle Mechanism

  • Shinya Kobayashi (Orthopedic Surgeon, RD Clinic / Member, Japanese Society for Regenerative Medicine): Tissue Repair Using Stem Cells

  • Motoharu Hojo (Representative Director, CELL BANK Corp. / Founder, RD Clinic): "Skin Regenerative Medicine" Using Dermal Fibroblasts

5. International Chronic Disease Management Innovation & Integration Forum

  • Xie Baize (Global Founder, Hong Kong Baize Life Science & Biotech): Integrated Application of Herbal TCM and Functional Medicine in Chronic and Severe Diseases—A Systemic Solution from Functional Repair to Healthy Longevity

  • Chen Xiaohui (Advisor, Asian Association of Regenerative Medicine and Cell Health): Proactive Health Management: Full-Cycle Application of Oral Nutritional Intervention in Longevity Medicine

  • Mao Zhifeng (General Manager of Discipline Marketing, Dian Diagnostics): Empowering Chronic Disease & Anti-Aging: Integration of Multivariate Precision Testing, Evaluation, and Intervention

  • Dimitri Klock (European Wellness Group): Neurodevelopmental Disorders Covering Autism, Global Developmental Delay (GDD), Down Syndrome, and Cerebral Palsy

  • Bu Yinping (Head of Overseas Marketing, Asian Regenerative Medicine (Hong Kong)): WT1 Cancer Vaccine—A Personalized Tumor Defense Strategy Activating Body Immune Memory

  • Zheng Xiaojie (General Manager, Shanghai Jieyu Zhongxiang Health Tech): The Application of Functional Medicine in Chronic Disease Management

  • Satoshi Yamamura (Dean, CGM Medical Online Diagnosis & Treatment Platform): Traditional Clinic Transformation and New Directions for Imported Drug Distribution

  • Zhang Xiutao (Technical Lead, Xinchao Bio-Functional Medicine Center): Xinchao Functional Medicine Center—A New Proposition for Health Management

  • Yi Hao (VP, Shenhu Zhikang (Shanghai) Info Tech): AI Cracking the "Impossible Trinity" of Health Management Services

  • Tang Bin (Founder & Chief Expert, Newber Anti-Aging International Medical Group): Application of International Anti-Aging New Technologies—Letting Anti-Aging Enter Every Awakened Life!

  • Fu Suiqiu (Chairman, Shenzhen Ankangda Biotech Development): Synergistic Intervention of Functional Medicine and Bioenergetic Medicine: Unlocking the Dual Code of Mind-Body Tuning and Treating Multiple Diseases Together

  • Lv Yingliang (Founder, TAA Medical): Ovarian Anti-Aging (Menopause) Level 4 Management Plan

  • Xu Mengchao (General Manager, Xiong'an Miaoxin Medical Laboratory): Proactive Health Models in the AI Era

  • He Junjie (General Manager, Shanghai Huizhong Cell Biotech): Immunity Rapid Screening Revolution—A Non-Flow Detection Technology Platform for 20-Minute Fingertip Blood Rapid Screening of TBNK Immune Cells

  • Bei Yu (Deputy General Manager, Guangzhou Jinzhi Testing Tech): Scientific Basis and Precision Efficacy Evaluation of Functional Medicine Products for Anti-Aging

  • Liu Yu (Chief Expert, Huahe Shangyi (Beijing) Medical Health Tech): Letting Ecological Medicine Benefit Every Life

  • Wang Hong (General Manager, Beijing Jincheng Xingye Trading): Introduction to the Diagnostic & Therapeutic Synchronized Quantum Precision AI Health Age-Reversal System—Creating a Cell-Level Closed Loop of Life Reboot, Repair, Regeneration, and Age-Reversal

6. International Gut Microecology & Environment Reconstruction Forum

  • Wei Fangping (Founder, Bohou Health Technology): Application of Chronic Food Allergy Testing in Health Management

  • Zhongchuang Yike (Shanghai) Biotechnology:(Topic TBA)

  • Wen Wei (BD Director, Guangzhou Zhiyi Biotechnology): R&D of the Live Biotherapeutic Product SK10 for Chemotherapy-Associated Diarrhea

  • Liu Qiang (Co-founder & COO, Shanghai Ruiyi Biotechnology): Gut Health and a Centenarian Life—Personalized Precision Intervention in Gut Microecology

  • Zheng Haihui (Medical Director, Shanghai Ruiyi Biotechnology): Gut Flora Intervention Aiding Autism Treatment, Guarding the "Brain-Gut Axis" or Opening a New Path to Healthy Longevity

  • Liu Qingjun (Chief Advisor, Zhongke Microecology (Shandong)): Current Status and Future Trends of the Microecology Industry

  • Bu Hongqiang (Market Development GM, Zhongke Ami Bio-tech): Probiotic Fermentation of Medicine-Food Homologous Materials: Dual Regulation Mechanism and Health Management Innovation

  • Wang Jingsu (Chairman, Jiangxi Shantai Health Industry Development): New Hope for Tumor Treatment: PD-1 + Fecal Microbiota Transplantation + γδT Cell "New Triple Therapy"

  • Xia Xiaoxiao (Project Lead, Chengge Medical Group Innovation Center): From "Single-Product Intervention" to "Systemic Reconstruction"—Flora Transplantation Opens a New Dimension of Precision Medicine

  • Gu Jianwei (CEO, Shandong Gut Microecology Technology): Improving Microecology to Boost Big Health

  • Xiao Junsheng (CMO, Beijing Yuan'ao Biotechnology): Building a "Dual Flora" Synergistic Full-Chain Human Microecology Solution (Gut Flora + Intimate Flora)

  • Fang Yong (R&D Director, Harbin Meihua Biotech / Harbin Medical University): New Health Mechanisms of Probiotic Extracellular Vesicles

  • Wu Zhengwen (CEO, Junyizhi Biotech (Hangzhou)): Building Gut Microecology Movement Capacity—Frequent Gut Movement, Frequent Health

7. International Nutritional Conditioning Application Forum

  • Michael Ma (Founder, Alice Cross-Border Health Supplements): Burn, Block, and Solidify: The Golden Code to Rebooting the Body's Metabolic Engine

  • Dr. Alexander J. Audette, D.Ac., B.Eng. (Chief Science Officer, NADclinic): NAD and Cardiovascular Health: Exploring Cell Protection Mechanisms Based on Subcutaneous Injection Innovation

  • Chen Jie (Head of Overseas Marketing, Life Circle (Hong Kong) Overseas Medical): Brain Function Activation—Frontier Tech Empowering Brain Rehab and Cognitive Enhancement

  • Wen Xuejun (Chief Scientist / Co-founder, Cosail (Hangzhou) Biotech): The Role of Natural Plant Extracts in Nodule Elimination

  • Tu Li (General Manager, Hesheng Zhili Health Tech (Hong Kong)): "Hesheng Zhili" Decodes the Scientific Core and Empirical Value of NAD+ Cell-Level Anti-Aging

  • Tang Xinwen (General Manager, Japan YOSHIKI Co., Ltd.): NAD+ Application and OEM Contracting

  • Masayuki Shiozawa (Dean, Nishiazabu International Clinic): Medical Strategies for Height Management in Children and Adolescents

  • Sam Huang Bo (Product Director, Hong Kong Osen Co.): The Importance of Scientific Selenium Supplementation

8. The Power to Resist Time: Longevity Tech Innovation & Health Protection Forum

  • Zheng Siyu (CEO, ICOOLTECH): How to Transform Anti-Aging from Medical Care to a Scalable Consumer-Grade System

  • Zhang Xiaoyu (Deputy General Manager, Tianjin Dongyidong Tech): Resisting Time Begins with Embracing Low Temperatures: The Cold Tech of Next-Generation Anti-Aging and Longevity

  • Hou Ming (Postdoc at Cambridge/Fudan, PhD at Univ. of Lyon, Executive Dean of 31 International Regenerative & Longevity Medicine Research Institute): Longevity and Regenerative Medicine: How to Dramatically Extend Human Healthspan

  • Shang Chen (Co-founder & President, Anjinghui Group): How to Integrate Functional Medicine with Healing Scenarios into Business Operations

  • Gao Shijun (Marketing & Medical Director, Singlera Genomics): Methylation Spacetime: Decoding the Epigenetics of Aging—Innovative Exploration Based on Precision Testing and Longevity Medicine

  • Tan Jiewen (Distinguished Advisor, Shanghai 701 Institute Yangyuan Hyperbaric Oxygen Chamber Co.): The Positive Significance of Mild Hyperbaric Oxygen in Chronic Disease Management

  • RMD Artificial Intelligence Physical & Mental Testing System's New Application in Longevity Projects:(Topic TBA)

9. International Assisted Reproductive Technology Forum

  • Tamar Akhvlediani (Beta Plus Fertility Clinic): Hope Through Science: Advances in Fertility Treatment

  • Chen Yinuo (Executive Dean, Tulip International Reproductive Center): Investment Logic of the Overseas Assisted Reproduction Industry

  • Shen Churong (Partner & Marketing Director, Xiamen Shiguanjia Technology): Jin Housheng + IRMC: The Golden Combination Empowering Channels from Kinmen to Kyrgyzstan

  • Zhang Xin (Founder & CEO, IVF USA & POWER IVF): Analysis and Comparison of the Assisted Reproduction Service Markets in the US and Mexico

  • Hu Yihan (General Manager, Ciming Boao International Hospital): From "Cannot" to "Can"—Ovarian Stem Cell Activation for New High-Net-Worth Pregnancy Prep Client Groups

  • An Qi (Head of Mainland China, Vitabiotics USA): Precision Nutritional Support and Multidimensional Optimization Strategies for Female Reproductive Capacity Reserve

  • Guo Siwen (Head of China Region, CEF Reproductive & Gynecological Medical Group, USA): Collaborative Practice of Assisted Reproduction and Regenerative Medicine—CEF's Exploration and Cooperation Prospects

  • Fan Weilei (Investor/Partner, One life): The Importance of Patient Psychological Management During IVF

  • Masatomo Hanaoka (Dean, Hanaoka IVF Hospital / Medical Corporation Futabakai): "The Future of IVF" From "Technology" to "Regenerative Medicine"

  • Du Cong (Business Director, Colombia UCFC Reproductive Center): Danruo Reproductive Medical Group - Colombia UCFC Single Medical Tourism Destination

  • Hou Yuling (Ovarian Vitality Project Leader, Shouxi (Guangzhou) Health Management): Regenerative Medicine Targeted Ovarian Anti-Aging, Enhancing Fertility, and Delaying Menopause

  • Wang Pengfei (Channel Division GM / Partner, Xishuangbanna International Reproductive XRC+ Hospital): Becoming the Best-Reputation Xishuangbanna International Reproductive Center

V. Visitor Guide

Transportation:

  • Airport: ~30 minutes by taxi from Hongqiao Airport; ~50 minutes from Pudong Airport.

  • Subway: * Jing'an Temple Station (Lines 2/7/14) – 10-minute walk.

    • West Nanjing Road Station (Lines 12/13) – 15-minute walk.

  • Driving: Search "Shanghai Exhibition Center" (上海展览中心) on your GPS/navigation app.

Partner Hotels:(Mention "Zhenghe Exhibition Customer" for discounts)

  • Jing An Shangri-La, Shanghai: 305m away, from ¥1750/night

  • The Portman Ritz-Carlton, Shanghai: 613m away, from ¥1400/night

  • Holiday Inn Express Shanghai Jing'an Temple: 230m away, ¥850/night (breakfast included)

  • City Hotel Shanghai: 607m away, from ¥500/night

  • Yan'an Hotel Shanghai: 645m away, from ¥350/night

Next
Next

【4月上海CMTF】300家海外机构+国内龙头集结!200+全球医疗最强大脑齐聚,共筑产业融合新高度